Pomalidomide Capsule
Product Images NDC 59651-197

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Pomalidomide (NDC 59651-197). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Pomalidomide Fig1)

A Kaplan-Meier survival curve chart showing progression-free survival in months for two groups: HD-DEX (blue solid line) and POM+LD-DEX (red dashed line). The y-axis represents the proportion of subjects. A table below the chart lists the number of subjects at risk over time for each group. The chart includes statistical data comparing the two treatments, including log-rank p-value, hazard ratio, and median survival times.*

FDA Label Image

Package Label-principal Display Panel (4 mg (100 Capsules Bottle))

Pomalidomide Capsules 4 mg oral capsules label showing the product name, strength, and quantity of 100 capsules. The label includes a warning about potential human birth defects, and storage instructions at 20° to 25°C. Distributed by Aurobindo Pharma USA, Inc. with manufacturing in India. A barcode and coding area are also visible.*

FDA Label Image

Figure 2 (Pomalidomide Fig2)

A survival curve chart comparing overall survival in months for two groups: HD-DEX (solid blue line) and POM+LD-DEX (dashed red line). The y-axis shows the proportion of subjects surviving, ranging from 0 to 1. Below the x-axis is a table showing the number of subjects at risk at various time points. Statistical data including logrank p-value, hazard ratio, and median survival times are displayed on the chart.*

FDA Label Image

Package Label-principal Display Panel (1 mg (21 Capsules Bottle))

Label for Pomalidomide Capsules 1 mg by Aurobindo Pharma Limited, containing 21 capsules. The label includes a warning about potential human birth defects, dosage instructions to see prescribing information, storage conditions of 20° to 25°C, and distribution details by Aurobindo Pharma USA, Inc. The label features a barcode and specifies that it is Rx only.*

FDA Label Image

Package Label-principal Display Panel (1 mg (100 Capsules Bottle))

Pomalidomide Capsules 1 mg oral capsules label from Aurobindo Pharma Limited. The label includes a warning about potential human birth defects and directs pharmacists to dispense the medication guide. It shows package size as 100 capsules, storage instructions at 20° to 25°C, distributor information for Aurobindo Pharma USA, and a barcode.*

FDA Label Image

Package Label-principal Display Panel (2 mg (21 Capsules Bottle))

Pomalidomide Capsules 2 mg label showing the dosage strength and quantity of 21 capsules. The label includes a boxed warning about potential human birth defects, dosage instructions referring to the prescribing information, storage conditions (20° to 25°C), and distributor details for Aurobindo Pharma USA, Inc. The label also includes a barcode and the note that the product is Rx only.*

FDA Label Image

Package Label-principal Display Panel (2 mg (100 Capsules Bottle))

Label for Pomalidomide Capsules 2 mg oral capsules by Aurobindo Pharma Limited. The label indicates the product contains 2 mg of pomalidomide per capsule and is provided in a package of 100 capsules. The label includes warnings about potential human birth defects, storage instructions, and distributor information for Aurobindo Pharma USA, Inc.*

FDA Label Image

Package Label-principal Display Panel (3 mg (21 Capsules Bottle))

Label for Pomalidomide Capsules 3 mg oral dosage form by Aurobindo Pharma Limited. The label includes a warning about the potential for human birth defects and instructs pharmacists to dispense the medication guide. It specifies the package contains 21 capsules and storage conditions at 20° to 25°C. The label also provides distributor information for Aurobindo Pharma USA, Inc. and a barcode.*

FDA Label Image

Package Label-principal Display Panel (3 mg (100 Capsules Bottle))

Label for Pomalidomide Capsules 3 mg, oral dosage form, containing 100 capsules. The label includes a warning about potential human birth defects and instructions for pharmacists to dispense a Medication Guide. It specifies storage conditions and lists Aurobindo Pharma USA, Inc. as the distributor, with manufacturing in India. The label shows product NDC 59651-196-01 and a barcode on the right.*

FDA Label Image

Package Label-principal Display Panel (4 mg (21 Capsules Bottle))

Label for Pomalidomide Capsules 4 mg by Aurobindo Pharma Limited. The label highlights the strength (4 mg), a warning about potential human birth defects, pharmacist dispensing instructions, and storage conditions. It indicates a package size of 21 capsules and distributor information for Aurobindo Pharma USA, Inc. The label includes an NDC number, barcode, and a note for overprinting and coding area.*

FDA Label Image

Chemical Structure (Pomalidomide Str)

Chemical structure of Pomalidomide showing its molecular components and bonds as a two-ring compound with amine and carbonyl groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.